To hear about similar clinical trials, please enter your email below
Trial Title:
EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem
NCT ID:
NCT05909020
Condition:
Head and Neck Cancer
Conditions: Official terms:
Head and Neck Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
No intervention.
Description:
No intervention.
Arm group label:
Patients
Arm group label:
Staff
Summary:
Can a patient-reported symptom-based risk stratification system improve the suspected
head and neck cancer (HNC) pathway?
Our methodology includes six interlinked work packages to deliver our aim, with
EVEREST-HN 1 encompassing the first of these and seeking to optimise a patient-reported
symptom inventory for HNC and outline requirement specification for the SYmptom iNput
Clinical (SYNC) system.
Detailed description:
The EVEREST-HN pathway should be based on a comprehensive understanding of existing HNC
diagnostic pathways and what patients and clinicians value in these. The language used
within the EVEREST pathway needs to be accessible and optimal to elicit appropriate
information.
Criteria for eligibility:
Study pop:
Patients Recruitment will aim for variation in age, ethnicity, socio-economic status,
presenting symptoms.
Clinicians Clinical staff involved in HNC diagnosis. Varying in seniority (consultant,
registrar) and specialty (ENT, maxillofacial)
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
Patients:
- Adults ≥ 18 years referred via suspected HNC pathway without previous history of HNC
- Participants willing and able to give informed consent for participation in the
study.
Clinicians:
- Staff at participating sites involved in the diagnostic pathway for people with
suspected HNC.
Exclusion Criteria:
- Individuals who do not meet the inclusion criteria.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Leeds Teaching Hospitals NHS Trust
Address:
City:
Leeds
Country:
United Kingdom
Status:
Not yet recruiting
Contact:
Last name:
Unknown Unknown
Investigator:
Last name:
James Moor
Email:
Principal Investigator
Facility:
Name:
Liverpool University Hospitals NHS Foundation Trust
Address:
City:
Liverpool
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
Shirley Pringle
Investigator:
Last name:
Katharine Davies
Email:
Principal Investigator
Facility:
Name:
Luton & Dunstable University Hospital
Address:
City:
Luton
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
Nithin George
Investigator:
Last name:
Chrysostomos Tornari
Email:
Principal Investigator
Facility:
Name:
Oxford NHS Foundation Trust
Address:
City:
Oxford
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
Iqbal Mohammed
Investigator:
Last name:
Stuart Winter
Email:
Principal Investigator
Start date:
March 17, 2023
Completion date:
November 30, 2023
Lead sponsor:
Agency:
Royal Marsden NHS Foundation Trust
Agency class:
Other
Collaborator:
Agency:
University of Leeds
Agency class:
Other
Source:
Royal Marsden NHS Foundation Trust
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05909020
